Victoria Thieberger – Page 2

CVC, Goldman eye $3.8 billion debt-for-equity swap for Australia’s Nine: sources

August 23, 2021 at 1:43 p.m.

MELBOURNE (Reuters) - Goldman Sachs and private equity firm CVC Capital Partners Ltd have proposed a debt-for-equity swap for CVC's Australian television network Nine, two sources said on Monday, a...

CVC, Goldman eye $3.8 billion debt-for-equity swap for Australia’s Nine: sources

December 24, 2018 at 3:02 p.m.

MELBOURNE (Reuters) - Goldman Sachs and private equity firm CVC Capital Partners Ltd have proposed a debt-for-equity swap for CVC's Australian television network Nine, two sources said on Monday, a...

Australia’s Cochlear plans to return implant to market

August 23, 2021 at 11:51 a.m.

MELBOURNE (Reuters) - Cochlear Ltd, the world's biggest maker of hearing implants, pledged on Tuesday to relaunch its top-selling implant after pulling it from the market due to a manufacturing...

Australia’s Cochlear plans to return implant to market

May 13, 2019 at 7:49 p.m.

MELBOURNE (Reuters) - Cochlear Ltd, the world's biggest maker of hearing implants, pledged on Tuesday to relaunch its top-selling implant after pulling it from the market due to a manufacturing...

TPG eyes $3 billion joint bid for Australia’s Nine: sources

August 23, 2021 at 10:57 a.m.

MELBOURNE/SYDNEY (Reuters) - U.S. private equity firm TPG is considering partnering with a Hollywood media executive to bid for debt-laden Australian media company Nine Entertainment Co, sources said, in what...

TPG eyes $3 billion joint bid for Australia’s Nine: sources

December 24, 2018 at 10:00 a.m.

MELBOURNE/SYDNEY (Reuters) - U.S. private equity firm TPG is considering partnering with a Hollywood media executive to bid for debt-laden Australian media company Nine Entertainment Co, sources said, in what...

New Zealand firm to trial pig cells to treat Parkinson’s

August 23, 2021 at 4:41 a.m.

MELBOURNE (Reuters) - A New Zealand company plans to implant pig cells in the human brain in a clinical trial to treat Parkinson's disease and help improve movement and brain...

New Zealand firm to trial pig cells to treat Parkinson’s

May 13, 2019 at 5:36 p.m.

MELBOURNE (Reuters) - A New Zealand company plans to implant pig cells in the human brain in a clinical trial to treat Parkinson's disease and help improve movement and brain...

All Stories